Issue 21, 2018

Theranostic system based on NaY(Mn)F4:Yb/Er upconversion nanoparticles with multi-drug resistance reversing ability

Abstract

For synchronous theranostic systems, there are two areas of focus. These are: excellent in vivo imaging and a multi-drug resistance (MDR) reversing ability for chemotherapy. Upconversion nanoparticles (UCNPs) exhibiting bright red emission in the “optical window in biological tissue (600–1100 nm)” could be a very useful candidate, although there have only been a few reports on UCNP-based conjugates with a MDR reversal ability explored for chemotherapy. Herein, we report an innovative theranostic system (D-UNT) via binding of an antitumor drug (DOX) and a MDR reversal agent (TPGS) to NaY(Mn)F4:Yb/Er UCNPs (UN) with synthetic optimized red emission and properties. The in vitro study demonstrated that the D-UNT was uptaken into drug-resistant MCF-7/ADR cells via caveolin dependent endocytosis and overcame P-gp mediated efflux. The cytotoxicity was significantly promoted to be much higher than that of free DOX. Accordingly, our D-UNT illustrates an enhanced reversal ability for chemotherapy. Our in vivo study further indicated that the D-UNT had excellent therapeutic efficacy against MDR tumors with minimal organ toxicity detected. In vivo deep-tissue imaging showed that the D-UNT accurately diagnosed MDR tumors at a 1.5 cm depth with high-contrast luminescent signals. Thus, the D-UNT is an effective theranostic system for the diagnosis and therapeutic treatment of MDR tumors. The present work opens new pathways to engineering powerful theranostic agents to simultaneously target, image and kill deep-tissue MDR tumor cells.

Graphical abstract: Theranostic system based on NaY(Mn)F4:Yb/Er upconversion nanoparticles with multi-drug resistance reversing ability

Supplementary files

Article information

Article type
Paper
Submitted
10 Feb 2018
Accepted
02 May 2018
First published
05 May 2018

J. Mater. Chem. B, 2018,6, 3586-3599

Theranostic system based on NaY(Mn)F4:Yb/Er upconversion nanoparticles with multi-drug resistance reversing ability

X. Chen, J. Sun, H. Zhao, K. Yang, Y. Zhu, H. Luo, K. Yu, H. Fan and X. Zhang, J. Mater. Chem. B, 2018, 6, 3586 DOI: 10.1039/C8TB00416A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements